Abstract
In recent years, a new generation of information technology has provided sufficient technical support for the smart manufacturing industry. In order to promote the upgrading of China's pharmaceutical smart manufacturing industry, the direction of industrial upgrading and transformation will be discussed from the perspective of technological innovation. According to the input and output data of technological innovation in China's pharmaceutical manufacturing industry from 2007 to 2019, the DEA method is used to analyze the allocation of innovative resources in China's pharmaceutical manufacturing industry in recent years. The study found that the efficiency of technological innovation in China's pharmaceutical manufacturing industry fluctuated greatly from 2007 to 2019, with a low overall level and varying degrees of wasted resources. On this basis, an in-depth analysis of the system architecture of the pharmaceutical smart manufacturing industry under the Industry 4.0 environment was performed. Finally, four paths for the digital transformation of China's pharmaceutical manufacturing industry are proposed. Chinese pharmaceutical manufacturing companies need to use new technologies to carry out comprehensive intelligent upgrading and digital transformation to improve innovation efficiency.
Highlights
China’s smart manufacturing industry has made some achievements in recent years
Smart manufacturing exerts a profound influence on the pharmaceutical industry, leading to the following three development trends [1,2,3]. e first is improving the intelligence and information levels of the pharmaceutical industry and popularizing manufacturing execution systems to the production processes, thereby achieving the whole-process monitoring and management of drug quality. e second is innovation of the production techniques and enhancing the applications of computer-aided drug design, 3D printing, and virtual reality during research and development (R&D). e third is increasing industry concentration, shifting the market structure of the pharmaceutical industry based on industrial integration, and promoting the pharmaceutical industry to the international market
Before measuring the technological innovation efficiency of China’s pharmaceutical manufacturing industry, the Pearson correlation test should be performed on the input and output indicators. e results are shown in Table 3. e test results show that the correlation coefficient between innovation input and output indicators is more significant than 0.8 at the level of 1%, which has a strong correlation. erefore, the innovation input and output indicators selected in this paper are more reasonable, further measuring and analyzing technological innovation efficiency
Summary
In order to promote the upgrading of China’s pharmaceutical smart manufacturing industry, the direction of industrial upgrading and transformation will be discussed from the perspective of technological innovation. E study found that the efficiency of technological innovation in China’s pharmaceutical manufacturing industry fluctuated greatly from 2007 to 2019, with a low overall level and varying degrees of wasted resources. On this basis, an in-depth analysis of the system architecture of the pharmaceutical smart manufacturing industry under the Industry 4.0 environment was performed. Chinese pharmaceutical manufacturing companies need to use new technologies to carry out comprehensive intelligent upgrading and digital transformation to improve innovation efficiency
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
